The total return over the past 12 months is -30.96% vs. +16.94% for the S&P 500. So far it's up +19.86% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (30.96%) | +17.29% | (6.45%) | N/A | N/A | N/A |
| Total Return CAGR | (30.96%) | +17.29% | (6.45%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | +60.12% | +105.89% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Janux Therapeutics, Inc. (JANX)
| Year | Start price | End price | JANX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $13.80 | $16.54 | +19.86% | +14.51% | +5.35% |
| 2025 | $53.54 | $13.80 | (74.22%) | +17.72% | (91.94%) |
| 2024 | $10.73 | $53.54 | +398.97% | +24.89% | +374.08% |
| 2023 | $13.17 | $10.73 | (18.53%) | +26.19% | (44.72%) |
| 2022 | $19.73 | $13.17 | (33.25%) | (18.17%) | (15.08%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
